Stay updated on Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Sign up to get notified when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.

Latest updates to the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page
- Check7 days agoChange DetectedThe version history now shows Revision: v3.6.2 instead of v3.6.0. This records a newer revision in the study record history.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe history now shows that the study is no longer recruiting participants, reflecting its terminated status. It also records a revision update to version v3.6.0 and removes the earlier revision entry v3.5.5.SummaryDifference0.5%

- Check29 days agoChange DetectedRevision metadata on the study history page updated from v3.5.4 to v3.5.5, signaling a new revision of the record history.SummaryDifference0.1%

- Check50 days agoChange DetectedVersion v3.5.4 has been added to the Study Record Versions list. The previous version v3.5.3 has been removed, updating the history to reflect the latest revision.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry v3.5.3 was added to the Record History, and the previous revision v3.5.2 was removed. This updates the version history to reflect the latest revision of the study record.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.5.2 is now listed, replacing v3.5.0, indicating a minor version update to the page history.SummaryDifference0.1%

Stay in the know with updates to Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.